[Prognostic evolution of Graves' disease treated by synthetic antithyroid (author's transl)]

Ann Endocrinol (Paris). 1980 Nov-Dec;41(6):581-4.
[Article in French]

Abstract

A follow-up of at least 4 years after withdrawal of a medical treatment of 77 patients with Graves' disease is presented. The treatment consisted in Carbimazole (15-30 mg/d), LT3 (75 ug/d), Propranolol (30-60 mg/d), Hydroxyzine (75 mg/d). A normal thyroid suppressibility (20 mm 99m Tc uptake test) is obtained in patients without goiter faster than in those with goiter. A normal early uptake at the sixth month therapy is a good index for cure. Despite this result the authors recommend a treatment of 12 to 18 months duration because of the probable immunodepressive effect of the antithyroid drugs.

Publication types

  • English Abstract

MeSH terms

  • Antithyroid Agents / adverse effects
  • Antithyroid Agents / therapeutic use*
  • Carbimazole / therapeutic use
  • Graves Disease / drug therapy*
  • Humans
  • Hydroxyzine / therapeutic use
  • Prognosis
  • Propranolol / therapeutic use
  • Triiodothyronine / therapeutic use

Substances

  • Antithyroid Agents
  • Triiodothyronine
  • Hydroxyzine
  • Carbimazole
  • Propranolol